Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADI™ Discovery models. We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses. Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADI™ Discovery capability to generate outstanding value through: • Strong & long term strategic R&D collaborations (>100 people collaborating). • Dual business model : Contractual or Collaborative R&D programs. • External valorization of our collaborative R&D programs through out-licensing or spin-off. • Outstanding internal pipeline of programs ready for collaborations, and • Already 1 therapeutic spin-off, 1 exclusive out-license, 14 CADI™ successes independently validated by our clients/partners, 4 issued patents and 10 publications (for all details www.bmsystems.net). You have a question, we may have the ability to generate the answer through one of our 6 BMSystems’ solutions to critical & high impact issues. • GO-NO GO decision before product acquisition or for portfolio risk analysis. • GO-NO GO decision before next development phase. • R&D program Rescue for a program facing critical issues during its lifetime. • External R&D “B plan” program when the “A plan” cannot be rescued. • Exploratory Discovery program to discover novel causal mechanism concept • Novel Hypotheses discovery and novel thrapeutic and/or diagnostic solutions. For more and latest information: www.bmsystems.net